New‐generation anticancer drugs and medication‐related osteonecrosis of the jaw (MRONJ): Late onset 3 years after ipilimumab endovenous administration with a possible role of targe...

le Guida, Agostino, Perri, Francesco, Ionna, Franco, Ascierto, Paolo A., Grimaldi, Antonio M.
Foilsithe in Clin Case Rep (2020)

Sequencing of BRAF inhibitors and ipilimumab in patients with metastatic melanoma: a possible algorithm for clinical use

le Ascierto, Paolo A, Simeone, Ester, Giannarelli, Diana, Grimaldi, Antonio M, Romano, Anna, Mozzillo, Nicola
Foilsithe 2012

PD-L1 inhibitors in the pipeline: Promise and progress

le Vanella, Vito, Festino, Lucia, Strudel, Martina, Simeone, Ester, Grimaldi, Antonio M., Ascierto, Paolo A.
Foilsithe in Oncoimmunology (2017)

Immunotherapy in metastatic melanoma: a novel scenario of new toxicities and their management

le Simeone, Ester, Grimaldi, Antonio M, Festino, Lucia, Trojaniello, Claudia, Vitale, Maria G, Vanella, Vito, Palla, Marco, Ascierto, Paolo A
Foilsithe in Melanoma Manag (2019)

Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab

le Morello, Silvana, Capone, Mariaelena, Sorrentino, Claudia, Giannarelli, Diana, Madonna, Gabriele, Mallardo, Domenico, Grimaldi, Antonio M., Pinto, Aldo, Ascierto, Paolo Antonio
Foilsithe in J Transl Med (2017)

The role of BRAF V600 mutation in melanoma

le Ascierto, Paolo A, Kirkwood, John M, Grob, Jean-Jacques, Simeone, Ester, Grimaldi, Antonio M, Maio, Michele, Palmieri, Giuseppe, Testori, Alessandro, Marincola, Francesco M, Mozzillo, Nicola
Foilsithe 2012

Analysis of T and NK cells immune response in Ipilimumab treated Melanoma patients

le Tallerico, Rossana, Cristiani, Costanza M, Capone, Mariaelena, Madonna, Gabriele, Mallardo, Domenico, Simeone, Ester, Dominijanni, Andrea, Grimaldi, Antonio M, Colucci, Francesco, Ascierto, Paolo A, Carbone, Ennio
Foilsithe in J Transl Med (2015)

Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations

le Ascierto, Paolo A., Capone, Mariaelena, Grimaldi, Antonio M., Mallardo, Domenico, Simeone, Ester, Madonna, Gabriele, Roder, Heinrich, Meyer, Krista, Asmellash, Senait, Oliveira, Carlos, Roder, Joanna, Grigorieva, Julia
Foilsithe in J Immunother Cancer (2019)

Systems biology analysis of immune signaling in peripheral blood mononuclear cells (PBMC) of melanoma patients receiving ipilimumab; basis for clinical response biomarker identific...

le Hotson, Drew, Alvarado, Ryan, Conroy, Andrew, Putta, Santosh, Simeone, Ester, Esposito, Assunta, Capone, Mariaelena, Madonna, Gabriele, Grimaldi, Antonio M, Rosen, David, Liang, Spencer, Cesano, Alessandra, Ascierto, Paolo A, Hawtin, Rachael
Foilsithe 2013

PD-L1 expression with immune-infiltrate evaluation and outcome prediction in melanoma patients treated with ipilimumab

le Madonna, Gabriele, Ballesteros-Merino, Carmen, Feng, Zipei, Bifulco, Carlo, Capone, Mariaelena, Giannarelli, Diana, Mallardo, Domenico, Simeone, Ester, Grimaldi, Antonio M., Caracò, Corrado, Botti, Gerardo, Fox, Bernard A., Ascierto, Paolo A.
Foilsithe in Oncoimmunology (2018)

The abscopal effect: efficacy of radiotherapy in patients on progression after treatment with ipilimumab 3 mg/kg

le Grimaldi, Antonio M, Simeone, Ester, Giannarelli, Diana, Palla, Marco, Muto, Paolo, Falivene, Sara, Sandomenico, Fabio, Petrillo, Antonella, Curvietto, Marcello, Esposito, Assunta, Paone, Miriam, Caracò, Corrado, Ciliberto, Gennaro, Mozzillo, Nicola, Ascierto, Paolo A
Foilsithe 2013

Efficacy of radiotherapy in patients on progression after treatment with ipilimumab 3 mg/kg

le Grimaldi, Antonio M, Simeone, Ester, Giannarelli, Diana, Muto, Paolo, Falivene, Sara, Sandomenico, Fabio, Petrillo, Antonella, Curvietto, Marcello, Esposito, Assunta, Paone, Miriam, Palla, Marco, Caracò, Corrado, Ciliberto, Gennaro, Mozzillo, Nicola, Ascierto, Paolo A
Foilsithe 2014

Systems biology analysis of immune signaling in peripheral blood mononuclear cells (PBMC) of melanoma patients receiving ipilimumab; basis for response biomarker identification

le Hotson, Drew, Alvarado, Ryan, Conroy, Andy, Putta, Santosh, Simeone, Ester, Esposito, Assunta, Capone, Mariaelena, Madonna, Gabriele, Grimaldi, Antonio M, Rosen, David B, Liang, Spencer, Cesano, Alessandra, Cacciapuoti, Carmela, Ascierto, Paolo A, Hawtin, Rachael E
Foilsithe 2014

Frequency of circulating CD8+CD73+T cells is associated with survival in nivolumab-treated melanoma patients

le Capone, Mariaelena, Fratangelo, Federica, Giannarelli, Diana, Sorrentino, Claudia, Turiello, Roberta, Zanotta, Serena, Galati, Domenico, Madonna, Gabriele, Tuffanelli, Marilena, Scarpato, Luigi, Grimaldi, Antonio M., Esposito, Assunta, Azzaro, Rosa, Pinto, Antonio, Cavalcanti, Ernesta, Pinto, Aldo, Morello, Silvana, Ascierto, Paolo A.
Foilsithe in J Transl Med (2020)

Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy

le Grimaldi, Antonio M, Simeone, Ester, Giannarelli, Diana, Muto, Paolo, Falivene, Sara, Borzillo, Valentina, Giugliano, Francesca Maria, Sandomenico, Fabio, Petrillo, Antonella, Curvietto, Marcello, Esposito, Assunta, Paone, Miriam, Palla, Marco, Palmieri, Giuseppe, Caracò, Corrado, Ciliberto, Gennaro, Mozzillo, Nicola, Ascierto, Paolo A
Foilsithe 2014

Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy

le Mozzillo, Nicola, Simeone, Ester, Benedetto, Lucia, Curvietto, Marcello, Giannarelli, Diana, Gentilcore, Giusy, Camerlingo, Rosa, Capone, Mariaelena, Madonna, Gabriele, Festino, Lucia, Caracò, Corrado, Di Monta, Gianluca, Marone, Ugo, Di Marzo, Massimiliano, Grimaldi, Antonio M, Mori, Stefano, Ciliberto, Gennaro, Ascierto, Paolo A
Foilsithe in Oncoimmunology (2015)

A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutation

le Simeone, Ester, Scognamiglio, Giosuè, Capone, Mariaelena, Giannarelli, Diana, Grimaldi, Antonio M., Mallardo, Domenico, Madonna, Gabriele, Curvietto, Marcello, Esposito, Assunta, Sandomenico, Fabio, Sabbatino, Francesco, Bayless, Nicholas L., Warren, Sarah, Ong, SuFey, Botti, Gerardo, Flaherty, Keith T., Ferrone, Soldano, Ascierto, Paolo A.
Foilsithe in J Transl Med (2021)

Ipilimumab and Stereotactic Radiosurgery with CyberKnife(®) System in Melanoma Brain Metastases: A Retrospective Monoinstitutional Experience

le Borzillo, Valentina, Di Franco, Rossella, Giannarelli, Diana, Cammarota, Fabrizio, Scipilliti, Esmeralda, D’Ippolito, Emma, Petito, Angela, Serra, Marcello, Falivene, Sara, Grimaldi, Antonio M., Simeone, Ester, Festino, Lucia, Vanella, Vito, Trojaniello, Claudia, Vitale, Maria Grazia, Madonna, Gabriele, Ascierto, Paolo A., Muto, Paolo
Foilsithe in Cancers (Basel) (2021)

IL-15, TIM-3 and NK cells subsets predict responsiveness to anti-CTLA-4 treatment in melanoma patients

le Tallerico, Rossana, Cristiani, Costanza M., Staaf, Elina, Garofalo, Cinzia, Sottile, Rosa, Capone, Mariaelena, Pico de Coaña, Yago, Madonna, Gabriele, Palella, Eleonora, Wolodarski, Maria, Carannante, Valentina, Mallardo, Domenico, Simeone, Ester, Grimaldi, Antonio M., Johansson, Sofia, Frumento, Paolo, Gulletta, Elio, Anichini, Andrea, Colucci, Francesco, Ciliberto, Gennaro, Kiessling, Rolf, Kärre, Klas, Ascierto, Paolo A., Carbone, Ennio
Foilsithe in Oncoimmunology (2016)

FUTURE PERSPECTIVES IN MELANOMA RESEARCH. Meeting report from the “Melanoma Research: a bridge from Naples to the World. Napoli, December 5(th)–6 (th)2011”

le Ascierto, Paolo A, Grimaldi, Antonio M, Curti, Brendan, Faries, Mark B, Ferrone, Soldano, Flaherty, Keith, Fox, Bernard A, Gajewski, Thomas F, Gershenwald, Jeffrey E, Gogas, Helen, Grossmann, Kenneth, Hauschild, Axel, Hodi, F Stephen, Kefford, Richard, Kirkwood, John M, Leachmann, Sancy, Maio, Michele, Marais, Richard, Palmieri, Giuseppe, Morton, Donald L, Ribas, Antoni, Stroncek, David F, Stewart, Rodney, Wang, Ena, Mozzillo, Nicola, Marincola, Franco M
Foilsithe 2012